Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...

Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...

Adjuvants help boost the immune response to the antigen in the vaccine, and can also help with dose sparing, according to a ...

Novavax, Inc. reported a 3Q25 EPS loss and declining revenue, but beat revenue expectations and reaffirmed its FY25 guidance, driven by Sanofi partnership milestones. Novavax's heavy reliance on ...

The US Food and Drug Administration intends to put a ‘black box’ warning on COVID-19 vaccines, CNN reported on Friday, citing ...

The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...

The plan has not been finalized and may still change, CNN reported. It was not immediately clear whether the plans for the ...

The FDA will reportedly add a “black box” warning to Covid-19 vaccines as the Trump administration steps up its attack on ...

Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...